Characteristics of Patients With Opioid Use Disorder Associated With Performing Overdose Reversals in the Community: An Opioid Treatment Program Analysis

被引:16
作者
Katzman, Joanna G. [1 ,2 ,3 ]
Greenberg, Nina H. [4 ]
Takeda, Mikiko Y. [5 ]
Balasch, Monica Moya [1 ]
机构
[1] Univ New Mexico, Dept Neurosurg, Sch Med, MSC 10-5615, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Dept Psychiat, Albuquerque, NM 87131 USA
[3] Univ New Mexico, Coll Nursing, MSC 10-5615, Albuquerque, NM 87131 USA
[4] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA
[5] Univ New Mexico, Dept Pharm Practice & Adm Serv, Coll Pharm, Albuquerque, NM 87131 USA
关键词
characteristics; harm reduction; naloxone; opioid; overdose; INJECTION-DRUG USERS; HEROIN OVERDOSE; NALOXONE;
D O I
10.1097/ADM.0000000000000461
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: The primary outcome of this study is to identify characteristics of study participants in a large opioid treatment program (OTP) for opioid use disorder (OUD) who used take-home naloxone to perform 1 or more opioid overdose (OD) reversal(s) in the community. Methods: This 6-month prospective cohort study provided take-home naloxone and opioid OD education for 287 study participants with OUD. Characteristics associated with use of the take-home naloxone were determined from among 16 variables using multivariable logistic regression. Results: The study participants who had greater odds of using the take-home naloxone to perform OD reversals, compared to those who did not use the take-home naloxone, (a) received emergency room care themselves for OD (OR = 4.89, 95% CI 1.54-15.52, P = 0.007), (b) previously witnessed someone else OD (OR = 5.67, 95% CI 1.24-25.87, P = 0.025), (c) tested positive for 2 or more illicit substances at their 6-month urine analysis (OR = 5.26, 95% CI 1.58-17.54, P = 0.007) or were missing their 6-month urine analysis (OR = 3.46, 95% CI 1.42-8.43, P = 0.006). In addition, they had greater odds of being (d) less than 30 years old (OR = 2.80, 95% CI 1.02-7.66, P = 0.045), and (e) Hispanic (OR = 3.98, 95% CI 1.41-11.21, P = 0.009). Conclusions: This study prospectively identified several characteristics of patients enrolled in an OTP with increased odds of using take-home naloxone in their social networks. Future harm reduction efforts may benefit by using targeted characteristics to identify those most likely to use naloxone in their communities.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 50 条
  • [41] Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured to cohort
    Morgan, Jake R.
    Schackman, Bruce R.
    Weinstein, Zoe M.
    Walley, Alexander Y.
    Linas, Benjamin P.
    DRUG AND ALCOHOL DEPENDENCE, 2019, 200 : 34 - 39
  • [42] Outcomes Associated with Treatment with and Without Medications for Opioid Use Disorder
    Mutter, Ryan
    Spencer, Donna
    McPheeters, Jeffrey
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2023, 50 (04) : 524 - 539
  • [43] Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis
    Salwan, Aaron
    Hagemeier, Nicholas E.
    Tudiver, Fred
    Dowling-McClay, Karilynn
    Foster, Kelly N.
    Arnold, Jessie
    Alamian, Arsham
    Pack, Robert P.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (06) : E173 - E178
  • [44] Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
    Bazazi, Alexander R.
    Low, Patrick
    Gomez, Bryson O.
    Snyder, Hannah
    Hom, Jeffrey K.
    Soran, Christine S.
    Zevin, Barry
    Mason, Michael
    Graterol, Joseph
    Coffin, Phillip O.
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2024, 101 (02): : 245 - 251
  • [45] Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
    Larochelle, Marc R.
    Bernson, Dana
    Land, Thomas
    Stopka, Thomas J.
    Wang, Na
    Xuan, Ziming
    Bagley, Sarah M.
    Liebschutz, Jane M.
    Walley, Alexander Y.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (03) : 137 - +
  • [46] Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance: An Analysis of Medically Attended Opioid Overdose Events
    Alexander R. Bazazi
    Patrick Low
    Bryson O. Gomez
    Hannah Snyder
    Jeffrey K. Hom
    Christine S. Soran
    Barry Zevin
    Michael Mason
    Joseph Graterol
    Phillip O. Coffin
    Journal of Urban Health, 2024, 101 : 245 - 251
  • [47] Navigating Care Refusal and Noncompliance in Patients with Opioid Use Disorder
    Marshall, Kenneth D.
    Derse, Arthur R.
    Weiner, Scott G.
    Joseph, Joshua W.
    JOURNAL OF EMERGENCY MEDICINE, 2024, 67 (02) : e233 - e242
  • [48] Retrospective analysis of the use of a continuous naloxone infusion for opioid overdose
    Spadaro, Anthony
    Negroni, Natalie
    Scaglione, Jaclyn
    Nelson, Lewis
    Parris, Mehruba
    CLINICAL TOXICOLOGY, 2024, 62 : 85 - 85
  • [49] Distinguishing clinical factors associated with unintentional overdose, suicidal ideation, and attempted suicide among opioid use disorder in-patients
    Stover, Amanda N.
    Rockett, Ian R. H.
    Smith, Gordon S.
    LeMasters, Traci
    Scott, Virginia G.
    Kelly, Kimberly M.
    Winstanley, Erin L.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 153 : 245 - 253
  • [50] Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use
    Noam, Krista R.
    Schmutte, Timothy J.
    Pirard, Sandrine
    Bourdon, Carol
    Langless, Daniel
    Plant, Robert
    JOURNAL OF ADDICTION MEDICINE, 2023, 17 (03) : E199 - E201